For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP76

2141

Dr.Priya Chandil
Membership No Author Name Email Mobile
2141 Dr.Priya Chandil drpriya.mys@gmail.com 9739268383
Comprehensive Ophthalmology

Ophthalmic side effects of Anti-obesity drugs- An Emerging challange 

PURPOSE:To review ophthalmic adverse effects of contemporary anti-obesity medications and their implications for clinical practice.METHODS: Narrative review of  trials, studies, reviews, and case reports evaluating ocular complications associated with anti-obesity drugs.RESULTS:  GLP-1 receptor agonists(Semaglutide)have been associated with early worsening of diabetic retinopathy due to rapid HbA1c reduction. Few case reports shows possible association with NAION. Topiramate-containing therapies can precipitate acute bilateral ACG and myopic shift through ciliochoroidal effusion, requiring immediate drug discontinuation and medical management. Phentermine may cause mydriasis, blurred vision, dry eye, and rarely precipitate angle closure in predisposed individuals. Long-term Orlistat use may lead to vitamin A deficiency, resulting in nyctalopia, xerophthalmia, and retinal dysfunction. .CONCLUSION:Timely screening of  high risk cases will help in minimising ocular complications.

No Co-Author Selected